IRCCS Az. Osp. Universitaria San Martino- IST

Genova 16132

0 studies enrolling now · 3 studies all time

What they study most

Autologous Stem Cell Transplant, End Stage Kidney Disease, Metastatic or Unresectable Cutaneous Melanoma, Multiple Myeloma

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed